Therefore, based on their findings, they recommend a comprehensive eye exam for patients living with MG who experience vision ...

Dr Katherine Ruzhansky previews presentations on biomarkers, new therapies, and translational science at AANEM 2025.

Progression-free and overall survival outcomes in patients with cancer treated with immunotherapy could be related to thymic ...

Regeneron could be just a few months away from filing for approval of a therapy for the neuromuscular disorder generalised myasthenia gravis (gMG), cemdisiran, which can be dosed just four times a ...